These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14624100)

  • 21. [The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
    Sav H; Atalay MA; Unal E; Koç N
    Mikrobiyol Bul; 2012 Oct; 46(4):695-701. PubMed ID: 23188584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
    Shao PL; Huang LM; Hsueh PR
    J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1-->3)-beta-D-glucan antigens.
    Kedzierska A; Kochan P; Pietrzyk A; Kedzierska J
    Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):755-66. PubMed ID: 17671803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New therapies for fungal pneumonia.
    Maertens J; Meersseman W; Van Bleyenbergh P
    Curr Opin Infect Dis; 2009 Apr; 22(2):183-90. PubMed ID: 19276884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
    Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
    PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status of invasive fungal infections. New diagnostic techniques and antifungal agents].
    Gurguí M; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():1-6. PubMed ID: 19572428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empirical antifungal treatment: a valid alternative for invasive fungal infection.
    Vallejo C; Barberán J
    Rev Esp Quimioter; 2011 Sep; 24(3):117-22. PubMed ID: 21947092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [NEW STRATEGIES FOR THE MICROBIOLOGICAL DIAGNOSIS OF VISCERAL MYCOSES].
    Alanio A; Bretagne S
    Rev Prat; 2015 Dec; 65(10):1325-9. PubMed ID: 26979035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of Fungal Infections--The Italian Experience.
    Bassetti M; Righi E
    Semin Respir Crit Care Med; 2015 Oct; 36(5):796-805. PubMed ID: 26398544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy.
    Morrissey CO; Bardy PG; Slavin MA; Ananda-Rajah MR; Chen SC; Kirsa SW; Ritchie DS; Upton A
    Intern Med J; 2008 Jun; 38(6b):477-95. PubMed ID: 18588521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.
    Kourkoumpetis TK; Fuchs BB; Coleman JJ; Desalermos A; Mylonakis E
    Clin Infect Dis; 2012 May; 54(9):1322-31. PubMed ID: 22362884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive mold infections: recent advances in management approaches.
    Chandrasekar P
    Leuk Lymphoma; 2009 May; 50(5):703-15. PubMed ID: 19337880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent progress in the diagnosis of fungal infections in the immunocompromised host.
    Erjavec Z; Verweij PE
    Drug Resist Updat; 2002 Feb; 5(1):3-10. PubMed ID: 12127859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of hematopoietic stem transplantation: Fungal infections.
    Omrani AS; Almaghrabi RS
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):239-244. PubMed ID: 28636889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances and challenges in management of invasive mycoses.
    Patterson TF
    Lancet; 2005 Sep 17-23; 366(9490):1013-25. PubMed ID: 16168784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making the diagnosis of fungal infection: when to start treatment.
    Martino P; Girmenia C
    Int J Antimicrob Agents; 2000 Nov; 16(3):323-9. PubMed ID: 11091056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.
    Kawazu M; Kanda Y; Nannya Y; Aoki K; Kurokawa M; Chiba S; Motokura T; Hirai H; Ogawa S
    J Clin Microbiol; 2004 Jun; 42(6):2733-41. PubMed ID: 15184460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive fungal infections: evolving challenges for diagnosis and therapeutics.
    Ellis M
    Mol Immunol; 2002 May; 38(12-13):947-57. PubMed ID: 12009573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.